ISTH 2015 Congress

Lancet Haematol. 2015 Aug;2(8):e313-4. doi: 10.1016/S2352-3026(15)00133-7. Epub 2015 Aug 5.
No abstract available

Publication types

  • Congress

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use
  • Arthroscopy / adverse effects
  • Blood Loss, Surgical / prevention & control*
  • Dabigatran / administration & dosage
  • Dabigatran / therapeutic use
  • Factor VIII / therapeutic use
  • Hemophilia A / drug therapy*
  • Humans
  • Randomized Controlled Trials as Topic
  • Rivaroxaban / therapeutic use
  • Single-Domain Antibodies / therapeutic use
  • Venous Thromboembolism / prevention & control*

Substances

  • Antibodies, Monoclonal, Humanized
  • Anticoagulants
  • Single-Domain Antibodies
  • recombinant factor VIII N8
  • caplacizumab
  • F8 protein, human
  • Factor VIII
  • idarucizumab
  • Rivaroxaban
  • Dabigatran